Mesa Labs Reports Q2 2027 Revenue Growth and Improved EBITDA Margins
Mesa Labs (MLAB) reported second-quarter fiscal 2027 results characterized by steady revenue growth and significant margin expansion. Total revenue reached $62.3 million, a 2.6% year-over-year increase driven largely by the quality control segments. Adjusted EBITDA rose 21.1% to $17.3 million, benefiting from higher gross margins and disciplined operating expense management. The company saw strong performance in its SDC segment, which grew organically by 14.6% as production issues were resolved. While some segments like BPD and CG faced organic declines due to export-control delays and shipment timing, overall profitability improved with net income rising to $0.75 per diluted share. Management provided full-year guidance of $250 million to $255 million in revenue and reaffirmed a focus on debt reduction and cost savings.
Tickers: $MLAB
Topics: EBITDA increase fiscal year guidance revenue growth segment performance
Read the full article at Motley Fool
Part of the story Mesa Labs Reports Q2 2027 Revenue Growth and Improved EBITDA Margins (7 articles)